Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,786 GBX | -1.16% | -1.71% | -0.17% |
Apr. 15 | Hikma Pharmaceuticals PLC Announces Executive Changes | CI |
Mar. 11 | FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data | DJ |
Chart calendar Hikma Pharmaceuticals PLC
Upcoming events on Hikma Pharmaceuticals PLC
Past events on Hikma Pharmaceuticals PLC
2024-03-20 | Final dividend |
2024-02-22 07:00 am | Q4 2023 Earnings Call - Q&A |
2024-02-22 02:00 am | Q4 2023 Earnings Call - Pre recorded |
2024-02-22 02:00 am | Q4 2023 Earnings Release |
2024-01-10 12:45 pm | JPMorgan Healthcare Conference |
2023-11-14 10:00 am | Jefferies London Healthcare Conference |
2023-11-02 03:00 am | Q3 2023 Sales and Revenue Release - Trading Update |
2023-08-09 | Ex-dividend day for dividende intermédiaire |
2023-08-03 04:30 am | Q2 2023 Earnings Call - Q&A |
2023-08-03 02:00 am | Q2 2023 Earnings Call - Pre recorded |
2023-08-03 02:00 am | Q2 2023 Earnings Release |
2023-04-28 06:00 am | Annual General Meeting |
2023-04-28 02:00 am | Q1 2023 Sales and Revenue Release - Trading Statement |
2023-03-22 | Final dividend |
2023-02-23 06:00 am | FY 2022 Earnings Call - Q&A |
2023-02-23 02:00 am | FY 2022 Earnings Call - Pre recorded |
2023-02-23 02:00 am | FY 2022 Earnings Release |
2022-11-03 03:00 am | Q3 2022 Sales and Revenue Release - Trading Statement |
2022-08-17 | Ex-dividend day for dividende intermédiaire |
2022-08-04 05:30 am | Interim 2022 Earnings Call - Q&A |
Past dividends on Hikma Pharmaceuticals PLC
2024-03-20 | Final Payment 0.47 USD |
2023-08-09 | Interim Payment 0.25 USD |
2023-03-22 | Final Payment 0.37 USD |
2022-08-17 | Interim Payment 0.19 USD |
2022-03-16 | Final Payment 0.36 USD |
2021-08-18 | Interim Payment 0.18 USD |
2021-03-17 | Final Payment 0.34 USD |
2020-08-19 | Interim Payment 0.16 USD |
2020-03-18 | Final Payment 0.3 USD |
2019-08-21 | Interim Payment 0.14 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 203 2 169 1.58% | 2 341 2 328 0.54% | 2 553 2 506 1.86% | 2 517 2 493 0.94% | 2 875 2 850 0.88% | 2 956 |
EBITDA Million USD | Released Forecast Spread | 593 590 0.46% | 674 677 -0.48% | 727 732 -0.64% | 694 677 2.52% | 811 786 3.16% | 793 |
EBIT Million USD | Released Forecast Spread | 508 503 1.06% | 566 574 -1.36% | 632 641 -1.35% | 596 576 3.54% | 707 688 2.81% | 677 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 465 420 10.65% | 522 506 3.22% | 544 569 -4.39% | 233 449 -48.13% | 281 506 -44.44% | 547 |
Net income Million USD | Released Forecast Spread | 486 338 43.96% | 431 389 10.66% | 421 431 -2.38% | 188 330 -42.99% | 190 367 -48.28% | 419 |
EPS USD | Released Forecast Spread | 2,00 1,39 43.37% | 1,81 1,63 11.09% | 1,81 1,86 -2.93% | 0,84 1,51 -44.62% | 0,85 1,45 -41.44% | 1,90 |
Announcement Date | 27/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 160 1 130 2.62% | 1 132 1 070 5.78% | 1 209 1 201 0.69% | 1 216 1 177 3.3% | 1 337 1 277 4.73% | 1 213 1 219 -0.53% | 1 304 1 271 2.57% | 1 427 1 348 5.86% | 1 448 1 486 -2.56% |
EBIT Million USD | Released Forecast Spread | 282 279 1.08% | 309 258 19.77% | 296 285 3.86% | 300 286 4.9% | 306 295 3.73% | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 248 223 11.21% | ||||||||
Net income Million USD | Released Forecast Spread | 219 172 27.33% | ||||||||
EPS USD | Released Forecast Spread | 0,94 0,74 26.34% | ||||||||
Announcement Date | 27/02/20 | 07/08/20 | 25/02/21 | 06/08/21 | 24/02/22 | 04/08/22 | 23/02/23 | 03/08/23 | 22/02/24 |
Past sector events for Hikma Pharmaceuticals PLC
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HIK Stock
- Calendar Hikma Pharmaceuticals PLC